相关实验视频
Updated: Jan 11, 2026

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
Published on: October 2, 2018
雄激素受体及其同调剂在性别偏差疾病中的作用
Manuela Basso1, Caterina Marchioretti2, Simona Zito2
1Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, 38123, Trento, Italy.
由雄激素受体 (AR) 驱动的雄激素信号传递,有助于癌症和神经退行性疾病的性别差异. 像PRMT6和LSD1这样的表观遗传酶作为AR协活性剂,促进疾病进展并提供新的治疗点.
科学领域:
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 在瘤学瘤学.
- 神经科学是一个神经科学.
背景情况:
- 男性患某些癌症和神经退行性疾病的发病率更高.
- 由雄激素受体 (AR) 介导的雄激素信号与这些基于性别的差异有关.
- 了解AR活动对于解决这些健康差异至关重要.
研究的目的:
- 审查雄激素和AR活性在疾病中的作用.
- 专注于影响AR特异性的转录辅调器.
- 要突出PRMT6和LSD1作为AR联合激活剂的功能.
主要方法:
- 文献综述侧重于AR介导的信号传递.
- 分析表观遗传修饰剂 (PRMT6,LSD1) 作为AR联合激活剂的作用.
- 探索针对AR及其共同调节剂的治疗策略.
主要成果:
- PRMT6和LSD1,以表观遗传抑制而闻名,作为AR协活性剂起作用.
- 这些酶增强AR转录输出,有助于恶性转变和进展.
- 在受癌症影响的多种细胞类型中,PRMT6和LSD1起着重要的作用.
结论:
- AR,PRMT6和LSD1是癌症和神经退行症等性别差异性疾病的关键参与者.
- 向AR,PRMT6和LSD1为组合治疗策略提供了潜力.
- 这些见解对治疗癌症和神经退行性疾病有广泛的影响.
更多相关视频
10:51Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
08:36Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
Published on: October 24, 2019
相关概念视频
Sex-linked Disorders
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Co-activators and Co-repressors
Co-activators and Co-repressors
Testosterone: Functions and Regulation
Dosage Compensation
In addition to sexual development, the X chromosome has genes involved in autosomal functions such as brain development and the immune system. Therefore, males and females with distinct numbers of X chromosomes will...